Health Care [ 12/12 ] | Health Care Providers & Services [ 46/74 ]
NYSE | Common Stock
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development.
Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry.
The company licenses its technology.
It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers.
Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
Jun 13, 24 | -0.06 Increased by +74.35% | - |
Mar 13, 24 | -0.06 Increased by +72.24% | - |
Nov 3, 23 | -0.13 Increased by +22.47% | - |
Jun 14, 23 | -0.31 Decreased by -207.50% | - |
Mar 20, 23 | -0.23 Decreased by -360.00% | - |
Dec 12, 22 | -0.22 Decreased by -336.60% | - |
Oct 14, 22 | -0.17 Decreased by -342.86% | - |
Jun 9, 22 | -0.10 Decreased by -350.00% | - |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Jul 31, 24 | 7.53 M Decreased by -75.77% | -13.38 M Decreased by -165.96% | Decreased by -177.80% Decreased by -372.21% |
Apr 30, 24 | 8.02 M Decreased by -50.20% | -3.02 M Increased by +79.50% | Decreased by -37.65% Increased by +58.83% |
Jan 31, 24 | 8.55 M Decreased by -47.65% | -3.06 M Increased by +71.27% | Decreased by -35.79% Increased by +45.13% |
Oct 31, 23 | 7.81 M Decreased by -57.29% | -6.62 M Increased by +46.77% | Decreased by -84.76% Decreased by -24.64% |
Jul 31, 23 | 31.06 M Increased by +53.13% | 20.29 M Increased by +1.14 K% | Increased by +65.32% Increased by +710.33% |
Apr 30, 23 | 16.11 M Decreased by -38.57% | -14.73 M Decreased by -62.90% | Decreased by -91.44% Decreased by -165.19% |
Jan 31, 23 | 16.34 M Decreased by -52.01% | -10.66 M Decreased by -301.36% | Decreased by -65.22% Decreased by -736.37% |
Oct 31, 22 | 18.28 M Decreased by -31.08% | -12.43 M Decreased by -435.92% | Decreased by -68.00% Decreased by -677.64% |